Skip to main content
NCBI home page
Canadian Family Physician logoLink to Canadian Family Physician
. 1998 Nov;44:2345-9, 2356-60.

Taking on diabetes. Family doctors on the front lines of the battle against diabetes.

S B Harris, A C Macaulay
PMCID: PMC2277982  PMID: 9839041

Full text

PDF
2345

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Charles M. A., Balkau B., Vauzelle-Kervröedan F., Thibult N., Eschwège E. Revision of diagnostic criteria for diabetes. Lancet. 1996 Dec 14;348(9042):1657–1658. doi: 10.1016/S0140-6736(05)65719-4. [DOI] [PubMed] [Google Scholar]
  2. Charles M. A., Balkau B., Vauzelle-Kervröedan F., Thibult N., Eschwège E. Revision of diagnostic criteria for diabetes. Lancet. 1996 Dec 14;348(9042):1657–1658. doi: 10.1016/S0140-6736(05)65719-4. [DOI] [PubMed] [Google Scholar]
  3. Harris M. I., Flegal K. M., Cowie C. C., Eberhardt M. S., Goldstein D. E., Little R. R., Wiedmeyer H. M., Byrd-Holt D. D. Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988-1994. Diabetes Care. 1998 Apr;21(4):518–524. doi: 10.2337/diacare.21.4.518. [DOI] [PubMed] [Google Scholar]
  4. Harris M. I., Flegal K. M., Cowie C. C., Eberhardt M. S., Goldstein D. E., Little R. R., Wiedmeyer H. M., Byrd-Holt D. D. Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988-1994. Diabetes Care. 1998 Apr;21(4):518–524. doi: 10.2337/diacare.21.4.518. [DOI] [PubMed] [Google Scholar]
  5. Harris M. I. Undiagnosed NIDDM: clinical and public health issues. Diabetes Care. 1993 Apr;16(4):642–652. doi: 10.2337/diacare.16.4.642. [DOI] [PubMed] [Google Scholar]
  6. Harris M. I. Undiagnosed NIDDM: clinical and public health issues. Diabetes Care. 1993 Apr;16(4):642–652. doi: 10.2337/diacare.16.4.642. [DOI] [PubMed] [Google Scholar]
  7. Jackson C. A., Yudkin J. S., Forrest R. D. A comparison of the relationships of the glucose tolerance test and the glycated haemoglobin assay with diabetic vascular disease in the community. The Islington Diabetes Survey. Diabetes Res Clin Pract. 1992 Aug;17(2):111–123. doi: 10.1016/0168-8227(92)90156-l. [DOI] [PubMed] [Google Scholar]
  8. Jackson C. A., Yudkin J. S., Forrest R. D. A comparison of the relationships of the glucose tolerance test and the glycated haemoglobin assay with diabetic vascular disease in the community. The Islington Diabetes Survey. Diabetes Res Clin Pract. 1992 Aug;17(2):111–123. doi: 10.1016/0168-8227(92)90156-l. [DOI] [PubMed] [Google Scholar]
  9. Lewis E. J., Hunsicker L. G., Bain R. P., Rohde R. D. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group. N Engl J Med. 1993 Nov 11;329(20):1456–1462. doi: 10.1056/NEJM199311113292004. [DOI] [PubMed] [Google Scholar]
  10. Lewis E. J., Hunsicker L. G., Bain R. P., Rohde R. D. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group. N Engl J Med. 1993 Nov 11;329(20):1456–1462. doi: 10.1056/NEJM199311113292004. [DOI] [PubMed] [Google Scholar]
  11. Pyorälä K., Pedersen T. R., Kjekshus J., Faergeman O., Olsson A. G., Thorgeirsson G. Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S) Diabetes Care. 1997 Apr;20(4):614–620. doi: 10.2337/diacare.20.4.614. [DOI] [PubMed] [Google Scholar]
  12. Pyorälä K., Pedersen T. R., Kjekshus J., Faergeman O., Olsson A. G., Thorgeirsson G. Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S) Diabetes Care. 1997 Apr;20(4):614–620. doi: 10.2337/diacare.20.4.614. [DOI] [PubMed] [Google Scholar]
  13. Ravid M., Lang R., Rachmani R., Lishner M. Long-term renoprotective effect of angiotensin-converting enzyme inhibition in non-insulin-dependent diabetes mellitus. A 7-year follow-up study. Arch Intern Med. 1996 Feb 12;156(3):286–289. [PubMed] [Google Scholar]
  14. Ravid M., Lang R., Rachmani R., Lishner M. Long-term renoprotective effect of angiotensin-converting enzyme inhibition in non-insulin-dependent diabetes mellitus. A 7-year follow-up study. Arch Intern Med. 1996 Feb 12;156(3):286–289. [PubMed] [Google Scholar]
  15. Sano T., Kawamura T., Matsumae H., Sasaki H., Nakayama M., Hara T., Matsuo S., Hotta N., Sakamoto N. Effects of long-term enalapril treatment on persistent micro-albuminuria in well-controlled hypertensive and normotensive NIDDM patients. Diabetes Care. 1994 May;17(5):420–424. doi: 10.2337/diacare.17.5.420. [DOI] [PubMed] [Google Scholar]
  16. Sano T., Kawamura T., Matsumae H., Sasaki H., Nakayama M., Hara T., Matsuo S., Hotta N., Sakamoto N. Effects of long-term enalapril treatment on persistent micro-albuminuria in well-controlled hypertensive and normotensive NIDDM patients. Diabetes Care. 1994 May;17(5):420–424. doi: 10.2337/diacare.17.5.420. [DOI] [PubMed] [Google Scholar]
  17. Tan M. H., MacLean D. R. Epidemiology of diabetes mellitus in Canada. Clin Invest Med. 1995 Aug;18(4):240–246. [PubMed] [Google Scholar]
  18. Tan M. H., MacLean D. R. Epidemiology of diabetes mellitus in Canada. Clin Invest Med. 1995 Aug;18(4):240–246. [PubMed] [Google Scholar]
  19. Worrall G., Chaulk P., Freake D. The effects of clinical practice guidelines on patient outcomes in primary care: a systematic review. CMAJ. 1997 Jun 15;156(12):1705–1712. [PMC free article] [PubMed] [Google Scholar]
  20. Worrall G., Chaulk P., Freake D. The effects of clinical practice guidelines on patient outcomes in primary care: a systematic review. CMAJ. 1997 Jun 15;156(12):1705–1712. [PMC free article] [PubMed] [Google Scholar]

Articles from Canadian Family Physician are provided here courtesy of College of Family Physicians of Canada

RESOURCES